Velagliflozin
Modify Date: 2024-01-04 10:39:31
Velagliflozin structure
|
Common Name | Velagliflozin | ||
|---|---|---|---|---|
| CAS Number | 946525-65-1 | Molecular Weight | 395.448 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 648.6±55.0 °C at 760 mmHg | |
| Molecular Formula | C23H25NO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 346.1±31.5 °C | |
Use of VelagliflozinVelagliflozin is an orally available sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity. |
| Name | velagliflozin |
|---|---|
| Synonym | More Synonyms |
| Description | Velagliflozin is an orally available sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity. |
|---|---|
| Related Catalog | |
| Target |
SGLT2[1] |
| In Vitro | Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity[1]. |
| In Vivo | Velagliflozin (1 mg/kg, p.o.) increases cholesterol, albumin, beta-hydroxybutyrate (BHB), nonesterified fatty acids (NEFA), and urinary glucose excretion, and decreases respiratory exchange ratio in cats[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 648.6±55.0 °C at 760 mmHg |
| Molecular Formula | C23H25NO5 |
| Molecular Weight | 395.448 |
| Flash Point | 346.1±31.5 °C |
| Exact Mass | 395.173279 |
| LogP | 3.87 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.670 |
| Storage condition | -20°C |
| velagliflozin |
| (1S)-1,5-Anhydro-1-[4-cyano-3-(4-cyclopropylbenzyl)phenyl]-D-glucitol |
| UNII:FV2YU8SL0P |
| D-Glucitol, 1,5-anhydro-1-C-[4-cyano-3-[(4-cyclopropylphenyl)methyl]phenyl]-, (1S)- |